AeroSafe Global, a NYC-based cold chain solution provider, raised $43M in funding.
The round was led by NewSpring, via NewSpring Health Capital, its dedicated healthcare fund, with participation from existing investors including Peloton Equity, Merck Global Health Innovation Fund, Hamilton Lane, Flexstone Capital, Wave Equity Partners, and Escalate Capital. As part of the transaction, Pete Buzy and Kapila Ratnam, Ph.D., are joining the AeroSafe Board of Directors. Buzy is the former Chairman of Gene Therapy at Catalent, Inc., and currently serves as an Advisory Partner for NewSpring’s dedicated healthcare funds. Ratnam is a Partner of NewSpring and the Firm’s dedicated healthcare funds with over 20 years of experience in the healthcare industry.
Led by CEO Jay McHarg, AeroSafe Global specializes in biopharmaceutical cold chain solutions, providing ‘Cold Chain as a Service’ (CCaaS) to ensure the safe, sustainable delivery and effective use of pharmaceuticals. Its service offering includes reusable thermal packaging, outsourced supply chain services, and a temperature monitoring control tower, all part of a pay-per-turn hassle-free program.
More than 45 biopharma companies use AeroSafe to deliver millions of shipments to hundreds of thousands of patients, providers, pharmacies, and hospital systems in 85 countries.
